These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene. Kunapuli P; Chitta KS; Cowell JK Oncogene; 2003 Jun; 22(26):3985-91. PubMed ID: 12821932 [TBL] [Abstract][Full Text] [Related]
13. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications. J Dabrowski M; Wojtas B Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166 [TBL] [Abstract][Full Text] [Related]
14. EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas. Erfani P; Tome-Garcia J; Canoll P; Doetsch F; Tsankova NM Epigenetics; 2015; 10(6):496-507. PubMed ID: 25996283 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis. Furuya K; Ikura M; Ikura T J Biochem; 2019 Apr; 165(4):297-299. PubMed ID: 30605533 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes in gliomas. Burgess R; Jenkins R; Zhang Z Cancer Biol Ther; 2008 Sep; 7(9):1326-34. PubMed ID: 18836290 [TBL] [Abstract][Full Text] [Related]
17. Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Piepoli T; Jakupoglu C; Gu W; Lualdi E; Suarez-Merino B; Poliani PL; Cattaneo MG; Ortino B; Goplen D; Wang J; Mola R; Inverardi F; Frassoni C; Bjerkvig R; Steinlein O; Vicentini LM; Brüstle O; Finocchiaro G Neuro Oncol; 2006 Apr; 8(2):96-108. PubMed ID: 16533756 [TBL] [Abstract][Full Text] [Related]
18. The role of epigenetic modifications, long-range contacts, enhancers and topologically associating domains in the regulation of glioma grade-specific genes. Grabowicz IE; Wilczyński B; Kamińska B; Roura AJ; Wojtaś B; Dąbrowski MJ Sci Rep; 2021 Aug; 11(1):15668. PubMed ID: 34341417 [TBL] [Abstract][Full Text] [Related]
19. Glioma epigenetics: From subclassification to novel treatment options. Gusyatiner O; Hegi ME Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066 [TBL] [Abstract][Full Text] [Related]
20. Histone Modifying Enzymes and Chromatin Modifiers in Glioma Pathobiology and Therapy Responses. Ciechomska IA; Jayaprakash C; Maleszewska M; Kaminska B Adv Exp Med Biol; 2020; 1202():259-279. PubMed ID: 32034718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]